Skip to content

Chemours CC Equity Method Investments

Equity Method Investments at other companies

Cabot Corporation logo
Cabot CorporationCBT
$18M+28.6%
Westlake logo
WestlakeWLK
$1.05B-2.4%
Albemarle logo
AlbemarleALB
$948.09M+28.9%
Dow logo
DowDOW
$224M+50.3%
Celanese Corporation logo
Celanese CorporationCE
$170M0.0%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD

Segments

By segment

See full
Advanced Performance Materials$93M+3.3%
Thermal And Specialized Solutions$73M-2.7%

Other financials

Income statement

See full
Revenue$1.4B+1.0%
Gross profit$212.0M-10.2%
Net income-$29.0M-480%
EPS (diluted)-$0.19-533%

Balance sheet

See full
Cash & equivalents$563.0M+21.3%
Total debt$4.4B0.0%
Total equity$215.0M-62.0%
Total assets$7.3B-1.5%

Cash flow

See full
Operating cash flow-$44.0M+60.7%
CapEx$49.0M-41.7%
Free cash flow-$93.0M+52.6%

Valuation

See full
Market cap$3B+63.6%

Profitability

See full
Gross margin15.1%-3.8pp
Net margin-7%-7.3pp
FCF margin5.1%-1.7pp

Returns & leverage

See full
Return on equity-105%-107pp
Debt / equity20.6×+12.8×
Current ratio1.8×+0.1×

Where this comes from

Reported directly by Chemours in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestments.

The official record: Chemours’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemours's equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemours's equity method investments?
Chemours (CC) reported equity method investments of $166M in Q1 2026.
How has Chemours's equity method investments changed year-over-year?
Chemours's equity method investments increased by 1.2% year-over-year, from $164M to $166M.
What is the long-term trend for Chemours's equity method investments?
Over 5 years (2020 to 2025), Chemours's equity method investments has grown at a -0.9% compound annual growth rate (CAGR), from $167M to $160M.
What does equity method investments mean?
Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.